Welcome : Guest
  • Only Report Titles
  • Titles & Keywords

CONTRACEPTIVES - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Contraceptives in US$ Million by the following product segments: Oral Contraceptives, Condoms, Implants/ Injections, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2007 through 2015. A seven-year historic analysis is also provided for these markets. The report profiles 164 companies including many key and niche players such as Ansell Limited, Bayer Schering Pharma AG, Church & Dwight Co. Inc., Conceptus, Inc., Condomi Health International GmbH, Female Health Company, Fuji Latex Co Ltd., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceutical Inc., Merck & Co., Inc., Okamoto Industries, Inc., SSL International PLC, Teva Pharmaceutical Industries Limited, Warner Chilcott, Pfizer Inc., and Wyeth Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Code : MCP-2528
Price : $4500
Companies : 164
Pages : 507
Date : October 2010
Market Data Tables : 112

Complimentary Copy of Study Findings:


Request a Complimentary Copy of the Study’s Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS

  CONTRACEPTIVES (Complete Report) Pages : 507   | $4500
 
  1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS.......14 $295  
   Study Reliability and Reporting Limitations.......1  
   Disclaimers.......2
Data Interpretation & Reporting Level.......2
  
   Quantitative Techniques & Analytics.......3
Product Definitions and Scope of Study.......3
Oral Contraceptives.......3
  
   Condoms.......4
Implants/Injections.......4
Other Contraceptives.......4
  
  2. INDUSTRY OVERVIEW........513 $1950  
   A Primer........5 1$100
   Table 1: World Contraceptive Use (2007): Percentage Share of Women in the Age Group of 15 to 49 Years Utilizing Contraceptives - Breakdown by Region and Type of Contraceptive Method........6

Table 2: Global Female Contraceptive Market (2007): Percentage Market Share Breakdown of Leading Players – Bayer, Johnson & Johnson, Schering-Plough, Barr Pharmaceuticals, Wyeth Laboratories, and Others (includes corresponding Graph/Chart)........6
1$350
   Table 3: Global Contraceptive Market: Percentage Share Breakdown of Leading Brands by Number of New Prescriptions (NRX) for the Month of January & June 2008 and January 2009 (includes corresponding Graph/Chart)........7
Impact of Recession: An Unequivocal Review........7
Cooling Economy Induces Changes in Childbearing Trends........7
1$350
   Recession Adds Fuel to Cost/Affordability Challenge........8
Rising Preference for Surgical Family Planning Procedures........8
Outlook........8
1$100
   Other Trends & Issues........9
Increasing Awareness Over STDs to Create Additional Demand for Condoms........9
HIV Prevalence and Incidence Statistics........9
1$100
   Table 4: Global Prevalence of HIV Infection by Region (2007 & 2008) in Millions (includes corresponding Graph/Chart)........101$350
   Table 5: HIV Prevalence in Select Countries (2007)........111$350
   Multifunctional Modern Contraceptives Make a Foray........12
Skin Sprays: A Novel Way of Contraception........12
Extensive Distribution Drives growth of Contraceptive Products........12
1$100
   Public Health Organizations Spur Condoms Use........13
USAID Worldwide Shipments of Condoms and Other Contraceptives........13
1$100
   Table 6: USAID Shipments of Condom and Other Contraceptives Worldwide (2008): Percentage Value Share Breakdown by Region –Africa, Asia/Near East, Latin America/the Caribbean, Europe/Eurasia, and Middle East (includes corresponding Graph/Chart)........14
Advertising for Contraceptives Acquires A Whole New Dimension........14
Manufacturers & Retailers Work in Sync to Accelerate Sales........14
1$350
   Innovation Keeps the Fire Burning for the Condoms Market........15
Generic & Biosimilar Contraceptive Products Gain Ground........15
Generics Manufacturers........15
1$100
   OTC Hormonal Contraceptives – An Attractive Market........16
R&D Companies & Generic Manufacturers - Developing Countries........16
1$100
   Commercial Success of R&D Brands Sustain Developmental Programs in Developing
  Countries........17
Challenges Facing Generic Contraceptive Products Manufacturers........17
1$100
  3. PRODUCT OVERVIEW........1846 $3950  
   Types of Contraception........18
The Contraceptive Timeline........18
1$100
   Table 7: World Contraceptive Prevalence (2005): Percentage Use of Select Contraception Methods In Less Developed and Developed Regions – Traditional Method, Pill, IUD, Condom, Implant/Injectables, Male Sterilization, Female Sterilization (includes corresponding Graph/Chart)........19
Classification........19
By Function........19
Barrier Contraceptives........19
1$350
   Characteristic Features of Barrier Methods........20
Hormonal Contraceptives........20
Prescription Contraceptives........20
Oral Contraceptives........20
1$100
   Overview of Oral Contraceptives - Benefits vs. Risks........21
Usage Levels of OCs in Worldwide Scenario........21
1$100
   Table 8: Percentage of Women in the age group 15-49 using contraception across select regions and countries for the years 2005 and 2006........22
Traditional and Modern........22
1$350
   Reversible and Permanent........23
Birth Control Methods and their Use in Major Regions Worldwide........23
1$100
   Contraception - Levels of Effectiveness........24
Effectiveness Index of Contraceptive Measures........24
2$200
   Unmet Need for Contraception........26
Segmental Analysis........26
A. Condoms........26
Overview........26
Categories........26
Latex Condoms........26
Non-Latex Condoms........26
1$100
   Skin Condoms........27
Polyurethane (PU) Condoms........27
Table 9: Leading Product Types in the US Condoms Market (2005) – Percentage Share Breakdown for Latex, Synthetic/Polyurethane and Natural (includes corresponding Graph/Chart)........27
Comparison Between Polyurethane & Latex Condoms........27
1$350
   Male Condom – Effectiveness of Protection Against STDs........28
Myths & Facts........28
Selection & Effective Use of Condoms........28
Condoms in the War Against AIDS........28
1$100
   Highlights........29
Growth Factors........29
1$100
   Factors Hindering Wide Spread Use of Condoms........30
Measures Aimed at Increasing Usage........30
Female Condoms........30
1$100
   Who are the Main Users?........31
Reality – An Effective Female Condom........31
B. Oral Contraceptives (OCs)/Pills........31
1$100
   A Peep into the Past........32
Synthetic Oral Contraceptives........32
Characteristic Features of Oral Contraceptives (OCs)........32
1$100
   Top Brands/Manufacturers of Oral Contraceptive Formulations Containing
  Levonorgestrel 0.15 MG/ Ethinyl Estradiol 30 mcg........33
1$100
   Table 10: Worldwide Hormonal Contraceptive Players (2005)- Market Share Breakdown by Leading Players: Schering AG, J&J, Barr, Wyeth, Watson, Akzo Nobel, and Others (includes corresponding Graph/Chart)........34
Bayer Schering Pharma’s “Yasmin”: A Resounding Brand Worldwide........34
1$350
   Table 11: Sales of Bayer Schering Pharma AG's Yasmin, and Yaz for the Years 2007 and 2009 (In Euro Millions)........35
Advantages of Using Ocs........35
Effects of Long-Term Use of OCs........35
1$350
   Use of OCs/Pills – Myths & Facts........36
Oral Contraceptives – Challenges & Strategies to Overcome Problems........36
1$100
   Factors Associated with Failure of OCs/Pills........37
Health Conditions to be Addressed when Using OCs........37
Understanding Risks Associated with Use of OCs........37
1$100
   Cardiovascular Disease – A Major Side Effect of OCs........38
Intake of OCs Result in High Blood Pressure........38
Smoking Intensifies Respiratory Problems in Pill Users........38
Complications Arising by Use of OCs Directly Related to Age........38
Relation Between OC and Cancer........38
1$100
   Depression Linked to Use of OCs........39
OCs Increases Osteoporosis Risk at Later Stage........39
OCs May Reduce Sex Drive........39
Effects of Pill on Childbearing Capacity........39
1$100
   Visiting a Doctor – Highly Recommended in Case of Warning Symptoms........40
Emergency Contraception (EC) – A New Face of OCs........40
Role of ECPs........40
1$100
   Effectiveness of ECP........41
Different Types of EC Products........41
Mini Pills........41
1$100
   RU486 - the French Abortion Pill........42
Top Brands/Manufacturers of Emergency Contraceptive Pills Containing
  Levonorgestrel 0.75 mg........42
1$100
   Top Brands/Manufacturers of Emergency Contraceptive Pills Containing
  Levonorgestrel 0.25mg and Ethinyl Estradiol 50mcg........43
Availability of Hormonal Contraceptives as OTC Drugs........43
C. Injectable Contraceptives........43
Depo-Provera........43
1$100
   Characteristic Features of Injectable Contraceptives........44
Injectables – Challenges & Strategies to Overcome Problems........44
1$100
   Top Brands & Manufacturers of Two & Three Month Injectable Contraceptive
  Formulations Containing Depot Medroxyprogesterone Acetate (DMPA), and
    Norethisterone Enanthate........45
1$100
   Top Brands & Manufacturers of Monthly Injectable Contraceptive Formulations
  Containing (Norethisterone Enanthate 50 mg and Estradiol Valerate 5 mg),
    (Dihydroxy Progesterone Acetophenide 75 mg and Estradiol Enanthate 5
      mg), (Medroxyprogesterone Acetate 25 mg and Estradiol Cypionate 5 mg),
        (Algeston acetophenide 150 mg and Estradiol Enanthate 10 mg), and
          Hydroxiprogesterone Caproate 250 mg........46
1$100
   D. Intrauterine Devices (IUDs)/Implants........47
Product Categories........47
CopperT 380A (ParaGard)........47
Progesterone T (or Progestasert)........47
1$100
   Characteristic Features........48
Benefits........48
Side Effects........48
1$100
   Challenges & Strategies to Overcome Problems........49
Table 12: IUD Users Worldwide (2005): Percentage Breakdown by Select Geographic Country/Region Geographic Country/Region IUD Users (includes corresponding Graph/Chart)........49
1$350
   Long-term Reversible Contraceptive Implants........50
Products........50
Norplant........50
Implanon........50
Mirena........50
1$100
   Characteristic Features of Implantable Contraceptives........51
Challenges & Strategies to Overcome Problems........51
1$100
   E. Spermicides........52
Product Categories........52
Benefits........52
Drawbacks........52
Contraceptive Foam........52
Delfen Contraceptive Foam........52
1$100
   Contraceptive Cream or Jelly........53
Encare Ovals........53
F. Diaphragms........53
G. Withdrawal & Douching........53
1$100
   H. Sterilization........54
Tubal Ligation........54
1$100
   Reasons Behind Adoption........55
Risk of Complications........55
Types........55
Abdominal Procedures........55
Laparoscopy........55
1$100
   Mini-Laparotomy........56
Laparotomy........56
Vaginal Procedures........56
Culdoscopy........56
Colpotomy........56
Hysterectomy – A High Risk Surgery........56
Selective Tubal Occlusion Procedure (STOP)........56
1$100
   Vasectomy........57
Method of Working........57
Reasons Behind Adoption........57
1$100
   Risk of Complications........58
I. Other Contraceptive Methods........58
Contraceptive Sponges........58
Today Sponge........58
1$100
   Characteristic Features of Today Sponge........59 1$100
   Table 13: Efficiency Rates of Today Sponge Based on Usage for 12-Month Period (includes corresponding Graph/Chart)........60
Allendale Pharmaceuticals........60
Protectaid Sponge........60
1$350
   Characteristic Features of Protectaid Sponge........61
Cervical Caps........61
Pros and Cons of the Device........61
1$100
   Vaginal Contraceptive Film (VCF)........62
Contraceptive Vaccine........62
Ortho Evra Weekly Contraceptive Patch........62
1$100
   NuvaRing Monthly Vaginal Ring........63
1$100
  4. RESEARCH AND DEVELOPMENT........643 $295  
   Oral Contraceptive Minimizes Premenstrual Syndrome Symptoms as per New Study........641$100
   Cause of Infertility - Not Associated with IUDs........65
Presence of Estrogen in OCs Offers Protection from Colorectal Cancer........65
Hormonal Contraceptive Usage & Risk Associated with Certain STDs........65
Use of Third Generation Ocs Increases Risk of Blood Clots........65
1$100
   High Risk of Deep Vein Thrombosis with Cyproterone- Containing OCs........66
1$100
  5. ROLE OF UNITED NATIONS IN PROMOTING USE OF CONTRACEPTIVES........6718 $3850  
   Female Condoms Reach New Heights with Aid from UNAIDS........67
Donor Support for Contraceptive Commodity........67
Table 14: Total Cost of Contraceptives and Condoms: 2000-2010E (In US$ Million) (includes corresponding Graph/Chart)........67
1$350
   Unmet Need........68
Table 15: Donor Support by Region: 2004 (includes corresponding Graph/Chart)........68

Table 16: Contraceptive Donor Support for STI/HIV Prevention by Agency: 1997-2004 (US$ 000)........68
1$350
   Donor Support by Contraceptive Method........69
Table 17: Donor Support by Contraceptive Method: 2000-2004 (In Thousand Units) (includes corresponding Graph/Chart)........69

Table 18: Donor Support for Contraceptive Method by Agency: 2000-2004 (In US$ Mill) (includes corresponding Graph/Chart)........69
1$350
   Donor Support by Top Ten Countries........70
Table 19: Major Donor Support Recipient Countries: 2004 (In US$ Million) (includes corresponding Graph/Chart)........70

Table 20: Donor Support for Condoms and Other Contraceptive Commodities: 1997-2004 (In terms of %) (includes corresponding Graph/Chart)........70
1$350
   Donor Funding For Male Condoms........71
Table 21: Donor Funding For Male Condoms: 2000- 2004 (includes corresponding Graph/Chart)........71

Table 22: Donor Funding For Male Condoms by Region: 2004 (includes corresponding Graph/Chart)........71
1$350
   Table 23: Number of Male Condoms Supplied by Donors: Region-Wise Breakup for year 2004........722$700
   Table 24: Donor Support for Condoms (1995-2004): Number of Condoms by Donor – USAID, UNFPA, BMZ/KfW, DFID, EU, DKT, PSI, IPPF, MSI, Netherlands, SIDA, and Japan (In Thousand Units) (includes corresponding Graph/Chart)........741$350
   Table 25: Donor Funding for Condoms (1995-2004): Number of Condoms by Donor – USAID, UNFPA, BMZ/KfW, DFID, EU, DKT, PSI, IPPF, MSI, Netherlands, SIDA, and Japan (In US$ 000) (includes corresponding Graph/Chart)........751$350
   Table 26: Total Number of Female Condoms in Private and Public Sectors: Region-wise Split from Years 1997 through 2004 (includes corresponding Graph/Chart)........76

Table 27: Percentage of Couples Using Condoms for Family Planning (2005) by Region........76
2$700
   Use of Modern Contraceptives Grows in Developing Regions........78 1$100
   Table 28: Estimated Numbers of Contraceptive Users in Developing Nations: 2000-2015 (In Millions) (includes corresponding Graph/Chart)........791$350
   Table 29: Comparative Study of Modern Contraception Methods in Developing Regions (including India & China) and Developing Regions (excluding India & China) - Percentage of Married Women Using Oral Contraceptives, Female Sterilization, and Intrauterine Devices (IUDs): Recent Past Data for 2000 (includes corresponding Graph/Chart)........80
Difference in Usage of Oral contraceptives in Developed and Developing World........80
Table 30: Oral Contraceptives Usage by Married and Sexually Active Unmarried Women (Aged 15-49 years) in Developed Regions including North America, Eastern Europe & Central Asia, and Australia & New Zealand: Recent Past Data for 2000........80
1$350
   Table 31: Oral Contraceptives Usage by Married and Sexually Active Unmarried Women (Aged 15-49 years) in Developing Regions including Asia, Near East & North Africa, Sub-Saharan Africa, Pacific Rim, and Latin America & Caribbean: Recent Past Data for 2000........81
Prevalence of Contraceptive Methods........81
Table 32: Increase in Contraceptive Usage by 2005 – Percentage Share Growth by Asia, Latin America and Africa (includes corresponding Graph/Chart)........81
1$350
   Table 33: Worldwide Contraceptives Market: Estimated Number of Users (2015 & 2025) – Asia, Latin America and Africa (includes corresponding Graph/Chart)........82

Table 34: Worldwide Contraceptive Market: Prevalence Amongst Women (2000-2025) – Percentage Share by Asia, Latin America and Africa (includes corresponding Graph/Chart)........82
United Nations Population Fund (UNFPA)........82
1$350
   UNFPA Gets Aid from Britain to Help Developing World........831$100
   Rise in Cost of Providing Contraceptives........84
Future Trends Worldwide........84
1$100
  6. NEW PRODUCT INTRODUCTIONS/ INNOVATIONS........855 $395  
   HLL Lifecare to Launch Pan Flavoured Condoms........85
Glenmark Generics Receives USFDA Approval for Norethindrone Tablets........85
HLL Lifecare to Introduce Moods in Australian Markets........85
Organon Releases Contraceptive NuvaRing........85
HRA Pharma Unveils ellaOne........85
1$100
   Bayer Introduces Qlaira New Oral Contraceptive........86
Durex Introduces Avanti Bare™........86
Teva to Introduce Tri-Lo Sprintec........86
Teva Announces Launch of Topiramate Tablets........86
Duramed Releases LoSEASONIQUE........86
1$100
   Uganda Health Marketing Group Rolls Out NewFem, A New Contraceptive Pill........87
TTK LIG to Unveil Durex Jeans Condoms........87
Teva Pharmaceutical Industries Receives Approval for Plan B One-Step Emergency
  Contraceptive........87
Cupid Limited to Unveil Cost-effective Female Condoms........87
1$100
   Bayer Schering Pharma Launches Qlaira®........88
Watson Laboratories Secures USFDA Approval for Plan B OTC Generics........88
Organon Launches Vaginal Contraceptive Ring........88
Bayer Schering Pharma Rolls Out Oral Contraceptive........88
1$100
   Hindustan Latex Introduces New Contraceptive Pill........89
FHI and HLL Launch Aastha Condom........89
NATCO Launches World-Class Oral Contraceptive........89
Bayer Plans Launch of Mirena in Japan........89
1$100
  7. RECENT INDUSTRY ACTIVITY........9015 $950  
   FHC Bags Order to Supply 3.5 Million FC2 Female Condoms for 2010 World Cup in South
  Africa........90
SSL Acquires Majority Stake in BLBV........90
Columbia Laboratories Inks Definitive Agreement with Watson Pharmaceuticals........90
1$100
   Piramal Healthcare Signs Definitive Agreement with Cipla........91
Watson Pharmaceuticals to Market HRA Pharma's Emergency Contraceptive........91
Lupin to Establish Three New Production Facilities........91
Pfizer to Purchase Wyeth........91
1$100
   Ansell Healthcare Signs Agreement with NYC Department of Health and Mental
  Hygiene........92
Teva Pharmaceutical Industries' Yaz Receives FDA Approval........92
Teva Pharmaceutical Industries' Yaz Receives Marketing Approval from FDA........92
Watson Pharmaceuticals, Warner Chilcott Collaborate for Femring........92
1$100
   Watson Pharmaceuticals Inks Agreement with Warner Chilcott for WC3026........93
Merck Merges with Schering-Plough........93
Vystar Inks Agreement with Centrotrade Minerals and Metals and Centrotrade
  Deutschland........93
1$100
   Mayer Laboratories Signs Agreement with Alvogen Group........94
Hypermarcas Acquires Inal........94
Sosei Inks Distribution Agreement with ASKA Pharmaceuticals........94
Sanofi-Aventis to Construct Plant in Brazil........94
Durex Chinese Plant Starts Production........94
1$100
   Patheon Expands Toronto Plant........95
Female Health Co Receives FDA Approval for Cheaper Female Condom........95
Mylan and Famy Care Sign Strategic Alliance for Exploring the US Oral Contraceptive
  Market........95
1$100
   Starpharma Holdings Signs Full License Agreement with SSL International Plc........96
SSL International to TakeOver Crest Condom Brand........96
Teva Pharmaceutical Industries Acquires Barr Pharmaceuticals........96
1$100
   Duramed Pharmaceuticals' LoSEASONIQUE® Receives FDA Approval........97
Bayer Schering Pharma's Qlaira® Receives Decentralized Drug Approval........97
Bayer and Barr Pharmaceuticals Sign Agreements........97
1$100
   Female Health's FC2 Receives FDA Approval........98
Faes Farma Signs Agreement with Gruenenthal........98
‘Female Health' Bags Order in Papua New Guinea........98
Mylan Enters into Alliance with Famy Care........98
1$100
   Bayer Schering Pharma to Launch YAZ Oral Contraceptive........99
Wuhan Humanwell Hi-Tech Industry to Expand Pharmaceutical Business........99
Watson Laboratories Receives FDA Approval........99
Organon Licenses Spray Technology from Acrux........99
1$100
   BioSante Initiates Phase II Trials of Oral Contraceptives........100
YAZ® Receives FDA Approval for New Indication........100
Paladin Labs Receives Approval to Market SEASONALE®........100
ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) Receives Two FDA Approvals
  (USA)........100
1$100
   Conceptus Receives FDA Approval for Third-Generation Essure ® Procedure........101
Wyeth Receives FDA Approval for Lybrel ™........101
NuvaRing® Completes European Authorization in 13 Countries........101
HLL Expands Promotion of Female Condom........101
1$100
   ChrysCapital Gains Minority Stake in Mankind Pharma........102
7 Chemicals Inks Deal with Ferring Pharmaceuticals........102
Synova Acquires Allendale Pharmaceuticals and Global Rights to Today Sponge........102
Ansell Pockets Blowtex........102
Bayer Merges with Berlex to Establish Bayer HealthCare Pharmaceuticals........102
1$100
   UNFPA Releases Pacific-Design Condoms........103
Wyeth Completes Acquisition of Wyeth K.K. Japan........103
Conceptus, Inc. to Acquire Conceptus SAS........103
Warner Chilcott Company Enters into a Supply Agreement with Watson Pharma........103
1$100
   SSL International Fully Acquires Qingdao London Durex Co Ltd........104
Bayer HealthCare Takes Over Marketing/Distribution Network of Pharmonyx Ltd.........104
1$100
  8. FOCUS ON SELECT PLAYERS........1056 $495  
   Ansell Limited (Australia)........105
Bayer Schering Pharma AG (Germany)........105
Church & Dwight Co., Inc. (US)........105
1$100
   Conceptus Inc (US)........106
Condomi Health International GmbH (Germany)........106
Female Health Company (US)........106
Fuji Latex Co Ltd (Japan)........106
1$100
   Johnson & Johnson (US)........107
Ortho-McNeil-Janssen Pharmaceutical Inc (US)........107
1$100
   Merck & Co., Inc (USA)........108
Okamoto Industries Inc (Japan)........108
SSL International PLC (UK)........108
Teva Pharmaceutical Industries Limited (Israel)........108
1$100
   Warner Chilcott (US)........109
Pfizer Inc (USA)........109
Wyeth Corporation (US)........109
2$200
  9. GLOBAL MARKET PERSPECTIVE........111   
   Table 35: World Recent Past, Current & Future Analysis for Contraceptives by Geographic Region - US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........1111$350
   Table 36: World Historic Review for Contraceptives by Geographic Region – US, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........1121$350
   Table 37: World 11-Year Perspective for Contraceptives by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........1131$350
   Table 38: World Recent Past, Current & Future Analysis for Oral Contraceptives by Geographic Region - US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........1141$350
   Table 39: World Historic Review for Oral Contraceptives by Geographic Region – US, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........1151$350
   Table 40: World 11-Year Perspective for Oral Contraceptives by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........1161$350
   Table 41: World Recent Past, Current & Future Analysis for Condoms by Geographic Region- US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........1171$350
   Table 42: World Historic Review for Condoms by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........1181$350
   Table 43: World 11-Year Perspective for Condoms by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........1191$350
   Table 44: World Recent Past, Current & Future Analysis for Implants/Injections by Geographic Region- US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........1201$350
   Table 45: World Historic Review for Implants/Injections by Geographic Region – US, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........1211$350
   Table 46: World 11-Year Perspective for Implants/Injections by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........1221$350
   Table 47: World Recent Past, Current & Future Analysis for Other Contraceptives by Geographic Region- US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........1231$350
   Table 48: World Historic Review for Other Contraceptives by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........1241$350
   Table 49: World 11-Year Perspective for Other Contraceptives by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........125
1$350
  10. THE UNITED STATES........12618 $2950  
   A. Market Analysis........126
Outlook........126
Restraints........126
Are Women's Reproductive Rights Getting Axed on the New Health Care Bill?........126
1$100
   Major Market Trends........127
Changing Consumer Demographics........127
1$100
   Relentless Promotional Programs Drive Home the Point........128
Use of Intimacy Products on the Rise........128
Generics Ransack the Branded Market........128
1$100
   Condoms – A ‘Fun, Inviting and Pleasurable’ Way to Healthy Life and Lifestyle........129
Market Share Statistics........129
Table 50: US Market for Male Contraceptives: Percentage Breakdown of Retail Dollar Sales of Key Players for the Year Ended January 2007 (includes corresponding Graph/Chart)........129
1$350
   Table 51: US Market for Male Contraceptives: Breakdown of Retail Unit Sales of Key Players for the Year Ended January 2007 (In 000 Units)........130

Table 52: US Market for Female Contraceptives: Percentage Breakdown of Retail Dollar Sales of Key Players for the Year Ended January 2007 (includes corresponding Graph/Chart)........130

Table 53: US Market for Female Contraceptives: Percentage Breakdown of Retail Unit Sales of Key Players for the Year Ended January 2007 (includes corresponding Graph/Chart)........130
1$350
   Table 54: US Market for Female Contraceptives: Percentage Breakdown of Dollar Sales of Leading Brands for the Year Ended March 2005 (includes corresponding Graph/Chart)........131

Table 55: US Condoms Market: Percentage Breakdown of Dollar Sales by Product Type for the Year Ended January 2006 (includes corresponding Graph/Chart)........131
Noticeable Shift in Retail Marketing Techniques........131
1$350
   Rising Use of Condoms Amongst Teenagers........132
Changing Attitudes and Perceptions Drive Market Sales........132
1$100
   Pill Continues to be One of the Most Popular Forms of Contraception........133
Oral Contraceptives and its Shades of Grey........133
Marketing Efforts Aimed at Influencing Female College Students........133
1$100
   Condoms Continuing Canter........134
Drug Stores Remain the Choice for Contraceptive Needs........134
Trade Class Statistics........134
1$100
   Oral Contraceptives – Unanimously the Choice of American Women........135
Table 56: Contraceptive Features Preferred by Women in US (includes corresponding Graph/Chart)........135
1$350
   Table 57: US Market for New Prescription (NRx) Oral Contraceptive (Estrogen/ Progestogen-based) Drugs (2006): Percentage Market Share Breakdown of Leading Players (includes corresponding Graph/Chart)........136

Table 58: US Market for Prescription (Rx) Oral Contraceptives: Percentage Market Share Breakdown of Leading Players for the Year 2007 (includes corresponding Graph/Chart)........136

Table 59: US Prescription Contraceptives Market: Percentage Market Share Breakdown for Select Product Categories for the Years 2007 (includes corresponding Graph/Chart)........136
1$350
   Table 60: US Market for Prescription Extended Cycle Oral Contraceptives: Percentage Market Share Breakdown for Leading Brands for the Years 2007 (includes corresponding Graph/Chart)........137
Health Facts........137
Rising Use of Oral Contraceptives........137
1$350
   Abortion Control Drugs & Methods........138
Medical Abortion........138
a. Mifepristone - A Medical Breakthrough........138
b. Methotrexate........138
Expanding the Use & Availability of EC Drugs........138
1$100
   Pharmacies Sell ECPs........139
Demographics........139
Facts and Figures........139
Sales of Contraceptives (Male & Female) – Family Planning Category........139
1$100
   Insurance Coverage for Contraceptives Still in Contest........140
Key Player........140
Watson Pharmaceuticals........140
1$100
   B. Market Analytics........141
Table 61: US Recent Past, Current & Future Analysis for Contraceptives by Product Segment- Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........141
1$350
   Table 62: US Historic Review for Contraceptives by Product Segment – Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........1421$350
   Table 63: US 11-Year Perspective for Contraceptives by Product Segment – Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/ Injections and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........143
1$350
  11. CANADA........1444 $950  
   A. Market Analysis........144
Scenario........144
Outlook........144
Condoms Market........144
1$100
   Immucon Obtains US Patent for Male Contraceptive Technology........145
B. Market Analytics........145
Table 64: Canadian Recent Past, Current & Future Analysis for Contraceptives by Product Segment- Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........145
1$350
   Table 65: Canada Historic Review for Contraceptives by Product Segment – Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........1461$350
   Table 66: Canadian 11-Year Perspective for Contraceptives by Product Segment – Percentage Breakdown of Dollar Sales Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........147
1$350
  12. JAPAN........1486 $950  
   A. Market Analysis........148
Outlook........148
Market for Oral Contraceptives Yet to Take Off........148
Innovation Expected to Drive Sales........148
1$100
   Major Issues and Trends........149
Domestic Products Dominate the Market........149
Health Care Institutions Remain Main Distribution Channels........149
Market Issues........149
Compulsory Labeling of Contraceptives........149
Late Approval for Use of OCs in Japan........149
1$100
   Factors Hindering Widespread Use of OCs........150
Condoms Market........150
Key Player........150
Sagami Rubber Industries Co., Ltd........150
1$100
   B. Market Analytics........151
Table 67: Japanese Recent Past, Current & Future Analysis for Contraceptives by Product Segment- Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........151
1$350
   Table 68: Japanese Historic Review for Contraceptives by Product Segment – Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........1521$350
   Table 69: Japanese 11-Year Perspective for Contraceptives by Product Segment – Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........153
1$350
  13. EUROPE........1547 $1950  
   A. Market Analysis........154
Outlook........154
Condoms Market........154
1$100
   B. Market Analytics........155
Table 70: European Recent Past, Current & Future Analysis for Contraceptives by Geographic Region – France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........155
1$350
   Table 71: European Historic Review for Contraceptives by Contraceptives by Geographic Region – France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........1561$350
   Table 72: European 11-Year Perspective for Contraceptives by Geographic Region – Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........1571$350
   Table 73: European Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........1581$350
   Table 74: European Historic Review for Contraceptives by Product Segment – Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........1591$350
   Table 75: European 11-Year Perspective for Contraceptives by Product Segment – Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/ Injections and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........160
1$350
  13a. FRANCE........1614 $950  
   A. Market Analysis........161
Outlook........161
Condoms Market........161
1$100
   B. Market Analytics........162
Table 76: French Recent Past, Current & Future Analysis for Contraceptives by Product Segment- Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........162
1$350
   Table 77: French Historic Review for Contraceptives by Product Segment – Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........1631$350
   Table 78: French 11-Year Perspective for Contraceptives by Product Segment – Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/ Injections and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........164
1$350
  13b. GERMANY........1654 $950  
   A. Market Analysis........165
Outlook........165
German Women Record Highest Usage Rate of Contraceptive Pill........165
Condoms Market........165
Table 79: Leading Players in the German Condoms Market (2005) - Percentage Share Breakdown by Sales Revenues - Sico, Vizit and Others-A Historic Review (includes corresponding Graph/Chart)........165
1$350
   B. Market Analytics........166
Table 80: German Recent Past, Current & Future Analysis for Contraceptives by Product Segment- Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........166
1$350
   Table 81: German Historic Review for Contraceptives by Product Segment – Oral Contraceptives, Condoms, Implants/ Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........1671$350
   Table 82: German 11-Year Perspective for Contraceptives by Product Segment – Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/ Injections and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........168
1$350
  13c. ITALY........1693 $950  
   A. Market Analysis........169
Outlook........169
B. Market Analytics........169
Table 83: Italian Recent Past, Current & Future Analysis for Contraceptives by Product Segment- Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........169
1$350
   Table 84: Italian Historic Review for Contraceptives by Product Segment – Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........1701$350
   Table 85: Italian 11-Year Perspective for Contraceptives by Product Segment – Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/ Injections and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........171
1$350
  13d. THE UNITED KINGDOM........1727 $1450  
   A. Market Analysis........172
Outlook........172
Overview........172
Changing Societal Trends........172
1$100
   Innovations: Need of the Hour........173
Table 86: Contraception Market in the United Kingdom: Percentage of Women Aged 16-49 Years Using Select Methods of Contraception As of the Year 2005-06 (includes corresponding Graph/Chart)........173
1$350
   Availability of Contraceptives........174
Contraceptive Injections........174
Emergency Contraception (EC)........174
Barrier Contraceptives........174
Major Trends and Issues........174
Hormone Based Products Overtake Barrier Products........174
Condoms Still Find Immense Favor in Britain........174
1$100
   Value of Condoms Declines Even as Volume Sales Increases........175
Table 87: Leading Players in the UK Condoms Market (2005) - Percentage Share Breakdown by Sales Revenues - Durex, Contex and Others - A Historic Review (includes corresponding Graph/Chart)........175
Role of Pharmacies in Improving Availability of Condoms and EC Drugs........175
Regulatory Environment........175
CEN Standards........175
1$350
   Advertising and Promotion........176
Hormone Based Contraceptives Restricted by Legislation........176
B. Market Analytics........176
Table 88: UK Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........176
1$350
   Table 89: UK Historic Review for Contraceptives by Product Segment – Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........1771$350
   Table 90: UK 11-Year Perspective for Contraceptives by Product Segment – Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........178
1$350
  13e. SPAIN........1794 $950  
   A. Market Analysis........179
Current & Future Analysis........179
Outlook........179
1$100
   B. Market Analytics........180
Table 91: Spanish Recent Past, Current & Future Analysis for Contraceptives by Product Segment- Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........180
1$350
   Table 92: Spanish Historic Review for Contraceptives by Product Segment – Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........1811$350
   Table 93: Spanish 11-Year Perspective for Contraceptives by Product Segment – Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/ Injections and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........182
1$350
  13f. RUSSIA........1833 $950  
   A. Market Analysis........183
Outlook........183
B. Market Analytics........183
Table 94: Russian Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........183
1$350
   Table 95: Russian Historic Review for Contraceptives by Product Segment – Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........1841$350
   Table 96: Russian 11-Year Perspective for Contraceptives by Product Segment – Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/ Injections and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........185
1$350
  13g. REST OF EUROPE........1865 $1450  
   A. Market Analysis........186
Outlook........186
Czech Republic........186
Denmark........186
Portugal........186
Table 97: Contraceptives Market in Portugal: Usage of Contraceptive Methods – Percentage Share by Condoms, OCs/Pill, Combination Method, Withdrawal and Calendar Method (includes corresponding Graph/Chart)........186
1$350
   Poland........187
Other Countries........187
1$100
   B. Market Analytics........188
Table 98: Rest of Europe Recent Past, Current & Future Analysis for Contraceptives by Product Segment- Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........188
1$350
   Table 99: Rest of Europe Historic Review for Contraceptives by Product Segment – Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........1891$350
   Table 100: Rest of Europe 11-Year Perspective for Contraceptives by Product Segment – Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........190
1$350
  14. ASIA-PACIFIC........19116 $1995  
   A. Market Analysis........191
Outlook........191
Market Primer........191
Greater Need for Contraception Awareness Among Adolescents........191
Oral Contraceptives Hold Potential for Growth........191
1$100
   Condoms Shortage Raise Fears of More HIV/AIDS Infections........192
Bangladesh........192
Indonesia........192
1$100
   Subsidized Condoms Clearly Dominate Other Products........193
Rise in Contraceptive Use and Decline in Fertility Characterizes
  Indonesia........193
Pakistan........193
The Philippines........193
Table 101: Use of Modern Contraceptive Methods in Philippines: Percentage Use of Select Contraceptive Methods Among Women in Union for the Year 2009 (includes corresponding Graph/Chart)........193
1$350
   Vietnam........194
China........194
Overview........194
Contraceptive Requirements........194
1$100
   14-Year Ban on Condom Advertising Finally Lifted........195
Condoms Witness Increasing Demand........195
India........195
Overview........195
1$100
   Rise in Population Fuels Growth........196
Family Planning, Need to Address Requirements........196
1$100
   Oral Contraceptives........197
Indian Women Fairly Open to the Concept of Oral Contraceptives........197
Free Distribution Scheme........197
Global Brands Still Alien to Indians........197
1$100
   Emergency Contraceptives -A Sunrise Segment........198
Social Marketing Scheme (SMS)........198
Goli Ke Hamjoli Campaign........198
Playing a Significant Role........198
1$100
   Contraceptives Distributed by Marketing Companies & NGOs Under Social
  Marketing Schemes........199
Condoms........199
Overview........199
1$100
   Supply........200
Market Segments........200
Female Condoms Foray in Indian Market........200
1$100
   Rest of Asia-Pacific........201
Australia........201
Sri Lanka........201
Bangladesh........201
Pakistan........201
1$100
   Factors Obstructing Improvement of Reproductive Health Status........202
Availability of Contraceptive Products/Devices........202
Thailand........202
Sex Education – Need of the Hour........202
1$100
   Table 102: Leading Players in the Thai Condoms Market (2005) - Percentage Share Breakdown by Sales Revenues - Durex, Contex and Others – A Historic Review (includes corresponding Graph/Chart)........203

Table 103: Leading Methods of Birth Control in the Thai Contraceptives Market (2005) -Percentage Share Breakdown - Sterilization, Birth Control Pills, Intra-Uterine Devices and Condom – A Historic Review (includes corresponding Graph/Chart)........203
Vietnam........203
1$350
   B. Market Analytics........204
Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Contraceptives by Product Segment- Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........204
1$350
   Table 105: Asia-Pacific Historic Review for Contraceptives by Product Segment – Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........2051$350
   Table 106: Asia-Pacific 11-Year Perspective for Contraceptives by Product Segment – Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........206
1$350
  15. LATIN AMERICA........2075 $950  
   A. Market Analysis........207
Outlook........207
Popular Contraceptives in Latin America and the Caribbean........207
Brazil........207
Contraceptives Market Grows Larger by the Day........207
1$100
   Role of Condom Social Marketing (CSM)........208
New Contraceptive Companies Face Tough Competition........208
Colombia........208
Ecuador........208
Guatemala........208
1$100
   Mexico........209
B. Market Analytics........209
Table 107: Latin American Recent Past, Current & Future Analysis for Contraceptives by Product Segment- Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)........209
1$350
   Table 108: Latin America Historic Review for Contraceptives by Product Segment – Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........2101$350
   Table 109: Latin American 11-Year Perspective for Contraceptives by Product Segment – Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........211
1$350
  16. REST OF WORLD........2126 $950  
   A. Market Analysis........212
Outlook........212
Middle East........212
Socio-Cultural Factors Influencing Use of Condoms........212
Oral Contraceptives Usage Patterns in Near East and Africa........212
Jordan........212
1$100
   Jamaica........213
Post Offices Playing Key Role in Improving Condom Accessibility........213
Africa........213
Female Condoms Gain Ground in South Africa........213
Uganda........213
Condoms – A Case of Anti-AIDS Success........213
1$100
   Kenya........214
Zimbabwe........214
Churches in Dilemma Over Condom Use in Zimbabwe........214
Other Countries........214
1$100
   B. Market Analytics........215
Table 110: Rest of World Recent Past, Current & Future Analysis for Contraceptives by Product Segment- Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........215
1$350
   Table 111: Rest of World Historic Review for Contraceptives by Product Segment – Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........2161$350
   Table 112: Rest of World 11-Year Perspective for Contraceptives by Product Segment – Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/ Injections and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........2171$350
COMPETITION 276$995
  
Total Companies Profiled: 164 (including Divisions/Subsidiaries - 189)

Region/Country                 Players


The United States                 42    
Canada                             3
Japan                              3
Europe                            35 
     France                        3
     Germany                      10 
     The United Kingdom            6
     Italy                         1
     Spain                         1
     Rest of Europe               14 
Asia-Pacific (Excluding Japan)    66 
Latin America                     35	 
Africa                             3
Middle-East                        2
Click here to request a full table of contents and more details on this project.		  
 
 

© Global Industry Analysts, Inc., USA. All Rights Reserved.
Visa Master American Verisign